GMO Emerging Country Debt Fund

5 / 5 Stars
5 5 1 5 1
Zacks Investment Research
1 (Strong Buy)
Standard & Poor's
5 / 5 Stars
C+ (Hold)

#1 in Emerging Markets Bond

U.S. News evaluated 101 Emerging Markets Bond Funds. Our list highlights the top-rated funds for long-term investors based on the ratings of leading fund industry researchers.

See all GMO funds

See full Emerging Markets Bond rankings

See more fund rankings


The fund has returned 17.00 percent over the past year, 12.55 percent over the past three years, 18.91 percent over the past five years, and 12.70 percent over the past decade.

Trailing Returns Updated 06.30.2014
Year to date 12.0%
1 Year 17.0%
3 Years (Annualized) 12.6%
5 Years (Annualized) 18.9%
10 Years (Annualized) 12.7%

See more GMCDX performance


The investment seeks total return in excess of that of its benchmark, the J.P. Morgan EMBI Global. The fund invests primarily in debt of emerging countries that is issued by a sovereign or its instrumentalities outside the country of the issuer and usually is denominated in the currency of the country in which it is issued (e.g., U.S. dollar, Euro, Japanese yen, Swiss franc and British pound sterling). Under normal circumstances, the fund invests directly and indirectly (e.g., through other GMO Funds or derivatives) at least 80% of its assets in debt investments tied economically to emerging countries. It is non-diversified.


Fees are Low compared to funds in the same category.
GMO Emerging Country Debt Fund has an expense ratio of 0.58 percent.

See more GMCDX fees


Risk is Above Average compared to funds in the same category according to Morningstar.

See more GMCDX risk